Ridgeback Capital Investments as of Dec. 31, 2013
Portfolio Holdings for Ridgeback Capital Investments
Ridgeback Capital Investments holds 5 positions in its portfolio as reported in the December 2013 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Sangamo Biosciences (SGMO) | 50.9 | $40M | 2.9M | 13.89 | |
Celldex Therapeutics | 31.4 | $25M | 1.0M | 24.21 | |
D Stemline Therapeutics | 12.6 | $9.9M | 507k | 19.60 | |
Arrowhead Research | 3.8 | $3.0M | 279k | 10.85 | |
Geron Corporation (GERN) | 1.4 | $1.1M | 225k | 4.74 |